55% Dividend In 2023: Pharma Stock Is Attractive To Buy, Target Price At Rs 1,010; 51% Potential Upside
Smallcap stock, Krsnaa Diagnostics is an attractive bet for fetching double-digit returns in the near term. The stock is currently moving towards its 52-week high. Brokerage JM Financial said that Krsnaa is participating in new, large tenders and will disclose further ...